BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8933143)

  • 1. Management of plasmapheresis in Germany.
    Müller N
    Hematol Cell Ther; 1996 May; 38 Suppl 1():S19-23. PubMed ID: 8933143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of plasmapheresis in France.
    Cazenave JP; Folléa G
    Hematol Cell Ther; 1996 May; 38 Suppl 1():S25-33. PubMed ID: 8933144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of plasmapheresis in Italy.
    Baldini GM
    Hematol Cell Ther; 1996 May; 38 Suppl 1():S9-18. PubMed ID: 8933142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Collection and utilization of plasma in Austria: on the way to national self-sufficiency].
    Bergmann H; Lukas M; Prusa P
    Beitr Infusionsther Transfusionsmed; 1996; 33():103-10. PubMed ID: 8974681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-sufficiency for plasma and plasma proteins in Norway.
    Solheim BG; Eggen BM; Heier HE
    Beitr Infusionsther Transfusionsmed; 1996; 33():98-102. PubMed ID: 8865939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic side of blood banking and plasma fractionation.
    Schneider W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(5):700-5. PubMed ID: 85581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA).
    Schulzki T; Seidel K; Storch H; Karges H; Kiessig S; Schneider S; Taborski U; Wolter K; Steppat D; Behm E; Zeisner M; Hellstern P;
    Vox Sang; 2006 Aug; 91(2):162-73. PubMed ID: 16907878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective trial on the safety of long-term intensive plasmapheresis in donors.
    Bechtloff S; Tran-My B; Haubelt H; Stelzer G; Anders C; Hellstern P
    Vox Sang; 2005 Apr; 88(3):189-95. PubMed ID: 15787729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Estimation of the blood donation necessary for self-sufficiency of blood products].
    Pinto V; Hernández Mejía R; Cueto A
    Sangre (Barc); 1999 Feb; 44(1):38-43. PubMed ID: 10323095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collection of source material from remunerated donors.
    Rodell MB
    Dev Biol Stand; 1993; 81():57-64. PubMed ID: 8174821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers.
    Tran-Mi B; Storch H; Seidel K; Schulzki T; Haubelt H; Anders C; Nagel D; Siegler KE; Vogt A; Seiler D; Hellstern P
    Vox Sang; 2004 Apr; 86(3):189-97. PubMed ID: 15078254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemapheresis activities in Germany.
    Moog R
    Transfus Apher Sci; 2005 Jun; 32(3):283-6. PubMed ID: 15944114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autologous plasmapheresis].
    Mehrkens HH; Geiger P; Weindler M; Wollinsky KH; Pohland H
    Klin Anasthesiol Intensivther; 1993; 43():146-60. PubMed ID: 8421377
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of an automated plasmapheresis procedure for the harvest of equine plasma in accordance with current good manufacturing practice.
    Ziska SM; Schumacher J; Duran SH; Brock KV
    Am J Vet Res; 2012 Jun; 73(6):762-9. PubMed ID: 22620688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Belgian plasmapheresis programme.
    Vermylen C
    Dev Biol Stand; 1980; 48():271-8. PubMed ID: 7274559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The German approach to emergency/disaster management.
    Domres B; Schauwecker HH; Rohrmann K; Roller G; Maier GW; Manger A
    Med Arh; 2000; 54(4):201-3. PubMed ID: 11117024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated automated plasmapheresis in goats (Capra hircus): a clinically safe and long-term refinement to current antibody recovery techniques.
    Klages C
    J Am Assoc Lab Anim Sci; 2006 Nov; 45(6):49-53. PubMed ID: 17089992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives of paid whole and plasma donation.
    Kretschmer V; Weippert-Kretschmer M; Slonka J; Karger R; Zeiler T
    Dev Biol (Basel); 2005; 120():101-11. PubMed ID: 16050162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustainability of a public system for plasma collection, contract fractionation and plasma-derived medicinal product manufacturing.
    Grazzini G; Ceccarelli A; Calteri D; Catalano L; Calizzani G; Cicchetti A
    Blood Transfus; 2013 Sep; 11 Suppl 4(Suppl 4):s138-47. PubMed ID: 24333307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Norwegian Plasma Fractionation Project--a 12 year clinical and economic success story.
    Flesland O; Seghatchian J; Solheim BG
    Transfus Apher Sci; 2003 Feb; 28(1):93-100. PubMed ID: 12620274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.